Dianthus Therapeutics, Inc. /DE/ (DNTH)
Since Aug 09, 2018, Dianthus Therapeutics, Inc. /DE/ (DNTH) has reported earnings 30 times. On average the shares move ±4.87% post-earnings, with a positive reaction 60.0% of the time. Its largest post-earnings gain was +21.52% (Mar 09, 2026) and its largest decline was -7.05% (May 06, 2021). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
30
Avg Abs. Movement
±4.87%
Positive %
60.0%
Negative %
40.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 05, 2026 | ☽ POST | $90.03 | $90.47 | $90.26 | 24,828 | +0.19% | open_in_new |
| Mar 09, 2026 | ☀ PRE | $78.90 | $84.86 | $79.23 | 4,611,200 | +21.52% | open_in_new |
| Nov 05, 2025 | ☽ POST | $33.00 | $34.09 | $33.73 | 380,400 | +8% | open_in_new |
| Aug 07, 2025 | ☽ POST | $20.42 | $20.89 | $19.15 | 245,800 | -2.04% | open_in_new |
| May 12, 2025 | ☽ POST | $20.32 | $21.44 | $20.08 | 178,000 | -6.18% | open_in_new |
| Mar 11, 2025 | ☽ POST | $24.23 | $24.32 | $23.38 | 300,000 | -6.33% | open_in_new |
| Nov 07, 2024 | ☽ POST | $29.71 | $30.13 | $29.90 | 194,500 | -2.81% | open_in_new |
| Aug 08, 2024 | ☽ POST | $25.88 | $27.07 | $26.74 | 91,100 | +2.84% | open_in_new |
| May 09, 2024 | ☽ POST | $23.86 | $25.20 | $24.93 | 70,500 | -2.57% | open_in_new |
| Mar 21, 2024 | ☽ POST | $27.15 | $28.46 | $27.94 | 287,300 | +14.32% | open_in_new |
| Nov 09, 2023 | ☽ POST | $11.42 | $11.42 | $11.41 | 6,200 | +0.79% | open_in_new |
| Feb 07, 2023 | ☽ POST | $13.12 | $13.92 | $13.12 | 358,206 | +3.66% | open_in_new |
| Nov 03, 2022 | ☀ PRE | $19.84 | $21.60 | $20.64 | 9,706 | +4.88% | open_in_new |
| Aug 04, 2022 | ☀ PRE | $27.84 | $28.32 | $27.20 | 4,263 | +4.29% | open_in_new |
| May 16, 2022 | ☀ PRE | $18.72 | $20.00 | $17.60 | 16,425 | -3.51% | open_in_new |
| Mar 08, 2022 | ☀ PRE | $41.60 | $46.24 | $43.68 | 11,100 | +7.06% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $128.00 | $133.92 | $133.28 | 11,313 | +2.84% | open_in_new |
| Aug 05, 2021 | ☀ PRE | $100.32 | $106.08 | $102.56 | 23,656 | +1.75% | open_in_new |
| May 06, 2021 | ☀ PRE | $181.28 | $186.08 | $168.64 | 7,406 | -7.05% | open_in_new |
| Mar 03, 2021 | ☀ PRE | $188.16 | $216.64 | $210.88 | 48,425 | +11.6% | open_in_new |
| Nov 05, 2020 | ☀ PRE | $107.20 | $108.32 | $105.60 | 6,750 | -0.9% | open_in_new |
| Aug 06, 2020 | ☀ PRE | $112.16 | $115.68 | $114.40 | 24,638 | +0.56% | open_in_new |
| May 07, 2020 | ☀ PRE | $155.84 | $159.52 | $155.84 | 9,813 | +2.74% | open_in_new |
| Mar 03, 2020 | ☀ PRE | $182.56 | $186.24 | $175.04 | 6,006 | -5.36% | open_in_new |
| Nov 13, 2019 | ☀ PRE | $166.40 | $173.44 | $164.00 | 5,675 | -2.19% | open_in_new |
| Aug 08, 2019 | ☀ PRE | $195.04 | $215.84 | $211.36 | 7,069 | +11.1% | open_in_new |
| May 09, 2019 | ☀ PRE | $238.56 | $256.00 | $246.40 | 7,131 | +2.67% | open_in_new |
| Mar 19, 2019 | ☀ PRE | $300.00 | $315.84 | $295.36 | 16,713 | +0% | open_in_new |
| Nov 08, 2018 | ☀ PRE | $144.64 | $144.64 | $140.96 | 1,894 | -3.4% | open_in_new |
| Aug 09, 2018 | ☽ POST | $211.36 | $216.64 | $214.24 | 1,481 | -2.91% | open_in_new |
Earnings Count
30
Total earnings in dataset
Avg Abs. Movement
±4.87%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260602 | open_in_new SEC.gov |
| 144 | 20260601 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 8-K | 20260522 | open_in_new SEC.gov |
Frequently asked about DNTH earnings
When does Dianthus Therapeutics, Inc. /DE/ report earnings next? expand_more
Dianthus Therapeutics, Inc. /DE/ (DNTH)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DNTH stock move after earnings? expand_more
Over 30 reports, DNTH has moved an average of ±4.87% the session after earnings, closing higher 60.0% of the time.
What was DNTH's biggest post-earnings move? expand_more
DNTH's largest post-earnings gain on record was +21.52% on Mar 09, 2026, and its largest decline was -7.05% on May 06, 2021.
Where can I find Dianthus Therapeutics, Inc. /DE/'s SEC filings? expand_more
All of Dianthus Therapeutics, Inc. /DE/'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right